NIIN Output Data
NIIN:
NSN:
Item Name:
CEFUROXIME SODIUM IN DEXTROSE IN
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC00338-2043-41 | 04687 | A | 5 | 9 | 4 | KX | ||
| ZINACEF INJECTION PREMIXED | 04687 | A | 5 | 1 | 4 | KX | ||
| NDC00173-0424-00 | 34006 | A | 3 | 2 | 4 | 54 | ||
| 2G3546 | 04687 | A | 3 | 2 | 4 | 54 | ||
| 1K0220 | 04687 | A | 5 | 9 | 4 | KX |
CAGE Information
| Code | Company |
|---|---|
| 04687 | BAXTER HEALTHCARE CORP IV SYSTEMS/GO |
| 34006 | GLAXO WELLCOME INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| FEAT | SPECIAL FEATURES | PREMIXED IN 5% DEXTROSE (D5W); FROZEN; SINGLE DOSE; NON-PYROGENIC; BAG W/AT LEAST ONE PERMANENTLY ATTACHED OUTLET PORT; FOR USE W/STOCKLISTED INTRAVENOUS INJECTION SETS |
| CQCT | PRIMARY CONTAINER TYPE | BAG WITH HANGING DEVICE, PLASTIC |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFUROXIME SODIUM IN DEXTROSE INJECTION 50ML BAG 24S |
| CSGS | ADMINISTRATION | INTRAVENOUS INFUSION |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 24 |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
| AJCN | PROTECTIVE STORAGE FEATURE | FROZEN FOR PRESERVATION |